These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 25633242)

  • 1. Overcoming adherence issues and other barriers to optimal care in gout.
    Nasser-Ghodsi N; Harrold LR
    Curr Opin Rheumatol; 2015 Mar; 27(2):134-8. PubMed ID: 25633242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CaseBook challenges: Managing gout, hyperuricemia and comorbidities -- dialogue with the experts.
    Bakris GL; Doghramji PP; Keenan RT; Silber SH
    Am J Med; 2014 Jan; 127(1):S1. PubMed ID: 24268074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolution of management of gout: a comparison of recent guidelines.
    Khanna PP; FitzGerald J
    Curr Opin Rheumatol; 2015 Mar; 27(2):139-46. PubMed ID: 25611299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Casebook consults: improving outcomes in gout (multimedia activity).
    Doghramji PP; Mandell BF; Pope RS
    Am J Med; 2012 Aug; 125(8):S1. PubMed ID: 22840678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient perspectives in gout: a review.
    Singh JA
    Curr Opin Rheumatol; 2019 Mar; 31(2):159-166. PubMed ID: 30575598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Facilitators and barriers to adherence to urate-lowering therapy in African-Americans with gout: a qualitative study.
    Singh JA
    Arthritis Res Ther; 2014 Mar; 16(2):R82. PubMed ID: 24678765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gout prevalence and predictors of urate-lowering therapy use: results from a population-based study.
    Pisaniello HL; Lester S; Gonzalez-Chica D; Stocks N; Longo M; Sharplin GR; Dal Grande E; Gill TK; Whittle SL; Hill CL
    Arthritis Res Ther; 2018 Jul; 20(1):143. PubMed ID: 29996922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gout medication treatment patterns and adherence to standards of care from a managed care perspective.
    Sarawate CA; Brewer KK; Yang W; Patel PA; Schumacher HR; Saag KG; Bakst AW
    Mayo Clin Proc; 2006 Jul; 81(7):925-34. PubMed ID: 16835972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Better outcomes for patients with gout.
    Day R; Nguyen A; Graham G; Aung E; Coleshill M; Stocker S
    Inflammopharmacology; 2020 Oct; 28(5):1395-1400. PubMed ID: 32095979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient Perspectives and Preferences Regarding Gout and Gout Management: Impact on Adherence.
    Chung MK; Kim SS; Cheon YH; Hong SJ; Choi HJ; Seo MR; Hwang J; Ahn JK; Lee SH; Min HK; Cha HS; Lee SS; Lee J; Moon KW; Lee CK; Kim HO; Suh YS; Shim SC; Kang SW; Kim J; Choi ST; Song JS; Lee J;
    J Korean Med Sci; 2021 Aug; 36(32):e208. PubMed ID: 34402226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term persistence and adherence on urate-lowering treatment can be maintained in primary care-5-year follow-up of a proof-of-concept study.
    Abhishek A; Jenkins W; La-Crette J; Fernandes G; Doherty M
    Rheumatology (Oxford); 2017 Apr; 56(4):529-533. PubMed ID: 28082620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medication adherence among patients with gout: A systematic review and meta-analysis.
    Scheepers LEJM; van Onna M; Stehouwer CDA; Singh JA; Arts ICW; Boonen A
    Semin Arthritis Rheum; 2018 Apr; 47(5):689-702. PubMed ID: 29198878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of hyperuricemia, gout and other crystalline arthritidies.
    Lioté F
    Reumatismo; 2012 Jan; 63(4):276-83. PubMed ID: 22303534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adherence with urate-lowering therapies among male patients with gout in a routine clinical setting.
    Lee S; So MW
    Mod Rheumatol; 2016 Nov; 26(6):950-955. PubMed ID: 27142782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The rate of adherence to urate-lowering therapy and associated factors in Chinese gout patients: a cross-sectional study.
    Yin R; Cao H; Fu T; Zhang Q; Zhang L; Li L; Gu Z
    Rheumatol Int; 2017 Jul; 37(7):1187-1194. PubMed ID: 28551724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A cross-sectional internet-based patient survey of the management strategies for gout.
    Singh JA; Shah N; Edwards NL
    BMC Complement Altern Med; 2016 Mar; 16():90. PubMed ID: 26931313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adherence to gout management recommendations of Chinese patients.
    Sheng F; Fang W; Zhang B; Sha Y; Zeng X
    Medicine (Baltimore); 2017 Nov; 96(45):e8532. PubMed ID: 29137059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adherence to gout guidelines: where do we stand?
    Ho GH; Pillinger MH; Toprover M
    Curr Opin Rheumatol; 2021 Mar; 33(2):128-134. PubMed ID: 33332889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rising burden of gout in the UK but continuing suboptimal management: a nationwide population study.
    Kuo CF; Grainge MJ; Mallen C; Zhang W; Doherty M
    Ann Rheum Dis; 2015 Apr; 74(4):661-7. PubMed ID: 24431399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rate of adherence to urate-lowering therapy among patients with gout: a systematic review and meta-analysis.
    Yin R; Li L; Zhang G; Cui Y; Zhang L; Zhang Q; Fu T; Cao H; Li L; Gu Z
    BMJ Open; 2018 Apr; 8(4):e017542. PubMed ID: 29643150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.